Holen Sie sich die Stockscreener-App
1.73
1.17%
0.02
Vorhandelsmarkt:
1.75
0.02
+1.16%
Schlusskurs vom Vortag:
$1.71
Offen:
$1.75
24-Stunden-Volumen:
484.14K
Relative Volume:
0.40
Marktkapitalisierung:
$169.42M
Einnahmen:
$97.06M
Nettoeinkommen (Verlust:
$-130.39M
KGV:
-1.1161
EPS:
-1.55
Netto-Cashflow:
$-186.54M
1W Leistung:
+5.81%
1M Leistung:
-6.99%
6M Leistung:
-70.33%
1J Leistung:
-70.58%
1-Tages-Spanne:
$1.70
$1.78
1-Wochen-Bereich:
$1.60
$1.79
52-Wochen-Spanne:
$1.60
$7.5773
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Vergleichen Sie ALEC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.73 | 169.42M | 97.06M | -130.39M | -186.54M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-09-25 | Eingeleitet | Goldman | Sell |
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Discovering 3 US Penny Stocks With Market Caps Below $200M - Simply Wall St
Alector, Inc. (NASDAQ:ALEC) Short Interest Update - MarketBeat
Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.75 - Defense World
Barclays PLC Buys 100,731 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Them too in TREM2: Street keeping AD Vigil - BioWorld Online
Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Average Price Target from Brokerages - MarketBeat
Alector stock hits 52-week low at $1.68 amid market challenges - Investing.com Canada
Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025 - GlobeNewswire
Alector Advances Brain Disease Pipeline: Key Trial Results Expected in 2025, $457M Cash Runway - StockTitan
Alector, Inc. Announces Termination of Al002 in Collaboration with Abbvie Biotechnology, Ltd - Marketscreener.com
Alector, Inc. (NASDAQ:ALEC) Stake Raised by JPMorgan Chase & Co. - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Acquired by JPMorgan Chase & Co. - MarketBeat
AbbVie terminates Alector collaboration agreement - MSN
Jane Street Group LLC Buys 30,180 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Geode Capital Management LLC Grows Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Reviewing BioNTech (NASDAQ:BNTX) & Alector (NASDAQ:ALEC) - Defense World
Alector stock hits 52-week low at $1.73 amid market challenges - Investing.com
State Street Corp Has $12.19 Million Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Stifel Financial Corp Sells 34,715 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (ALEC) Stock Dips Amid Mixed Analyst Ratings - GuruFocus.com
The Market Doesn't Like What It Sees From Alector, Inc.'s (NASDAQ:ALEC) Revenues Yet As Shares Tumble 53% - Simply Wall St
Critical Contrast: Relay Therapeutics (NASDAQ:RLAY) & Alector (NASDAQ:ALEC) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 10,920 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (NASDAQ:ALEC) Rating Lowered to “Neutral” at Mizuho - Defense World
BNP Paribas Financial Markets Cuts Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (NASDAQ:ALEC) Stock Rating Lowered by Mizuho - MarketBeat
Alector stock under pressure as key AL002 program removed—Mizuho - Investing.com India
Alector (NASDAQ:ALEC) Downgraded to “Hold” Rating by Stifel Nicolaus - Defense World
Alector stock under pressure as key AL002 program removed—Mizuho By Investing.com - Investing.com UK
Alector Inc. stock downgraded to Hold by Stifel, amid mixed biotechnology outlook - Investing.com Australia
Alector (NASDAQ:ALEC) Rating Lowered to "Hold" at Stifel Nicolaus - MarketBeat
Verition Fund Management LLC Sells 473,794 Shares of Alector, Inc. (NASDAQ:ALEC) - MarketBeat
Charles Schwab Investment Management Inc. Buys 94,145 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector stock hits 52-week low at $1.99 amid market challenges - Investing.com Australia
Short Interest in Alector, Inc. (NASDAQ:ALEC) Grows By 34.1% - MarketBeat
Alector, Inc. (NASDAQ:ALEC) Sees Large Growth in Short Interest - Defense World
Alector (ALEC) Stock Dips Amid Biotech Sector Volatility - GuruFocus.com
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):